Meeting Venue

Hotel Le Plaza Brussels
Adolphe Maxlaan 118/126
1000 Brussel, Belgium

Learning Objectives

Over two days of engaging presentation, discussion, debate and discovery, participants will:

• Discuss the current selection criteria for patients with knee arthritis that are likely to benefit from Total or unicompartmental knee arthroplasty.
• Incorporate the new protocols for joint arthroplasty in your practice using strategies for patient selection, peri-operative optimization and post-operative management.
• Discuss appropriate surgical technique, the concepts of alignment and balancing for performing unicompartmental knee arthroplasty, and primary and revision total knee arthroplasty.
• Diagnose and treat acute and chronic periprosthetic knee complications.
• Interpret the latest data and recommendations regarding evolving concepts in knee arthroplasty including outpatient surgery, robotic-assisted surgery, and new technologies.

Preliminary Meeting-at-a-Glance

Agenda

Program information, agendas and faculty details are subject to change. Please check back for the most up-to-date information.

07:45 - 08:00	Welcome to Day One The Theatre
07:45 - 08:00		Introduction		Translation
		Director: Myles R. J. Coolican, FRACS AUSTRALIA
		Director: Philippe Noel Neyret, MD, PhD, Prof. FRANCE

08:00 - 09:00	Session 1. Alignment The Theatre
08:00 - 09:00		Alignment		Translation
		Chair: Sebastien Lustig, MD, PhD, Prof. FRANCE
		David H. Figueroa, MD CHILE
		Philippe Noel Neyret, MD, PhD, Prof. FRANCE
		Sachin Tapasvi, MBBS, MS, DNB, FRCS INDIA
		Jan M. K. Victor, MD, PhD BELGIUM
		Simon W. Young, MD, FRACS NEW ZEALAND
		Moderator: Samuel J MacDessi, MBBS FRACS FAOrthA PhD AUSTRALIA
		At the conclusion of this session, all participants should have a clear understanding of: The meaning and goal of each described alignment strategy. Evidence for different alignment strategies. How to implement individual alignment strategies. When to use and not use certain alignment strategies. Techniques to restore the joint line.

09:00 - 10:00	Session 2. Ligament Balance in TKA The Theatre
09:00 - 10:00		Ligament Balance in TKA		Translation
		Chair: Peter James McEwen, MBBS FRACS(Orth) FAOrthA DIpModLang A/Prof AUSTRALIA
		James Chow, MD UNITED STATES
		Mark G. Clatworthy, FRACS NEW ZEALAND
		Guillaume Demey, MD FRANCE
		Samuel J MacDessi, MBBS FRACS FAOrthA PhD AUSTRALIA
		Moderator: Peter Verdonk, MD, PhD BELGIUM
		At the conclusion of this session, participants should have a clear understanding of the goals for ligament balance in arthroplasty and the clinical results.

10:30 - 11:15	Session 3. Implant Choices in 2026 The Theatre
10:30 - 11:15		Implant Choices in 2026		Translation
		Chair: Francesco Benazzo, MD, Prof. ITALY
		David H. Figueroa, MD CHILE
		Ken Okazaki, MD, PhD, Prof. JAPAN
		Andrew James Price, DPhil, FRCS(Orth) UNITED KINGDOM
		Bart Stuyts, MD BELGIUM
		Moderator: David A. Parker, MBBS, BMedSc, FRACS AUSTRALIA
		At the conclusion of this session, participants should have a clear understanding of: The advantages and disadvantages of the different options for Total Knee implants in 2026. How to choose the best implant for your patient. What is the plan and why. The effect of implant design on knee kinematics. The current evidence that surgeons require to allow an unbiased comparison of implant longevity and lifetime cost-effectiveness of the different knee replacement constructs. Patient population differences across the world are highlighted in some way.

11:15 - 11:45	Session 4. How to Implement Short Stay TKA in Your Surgical Practice The Theatre
11:15 - 11:45		How to Implement Short Stay TKA in Your Surgical Practice		Translation
		Chair: Daniel C. Wascher, MD UNITED STATES
		Claudia Arias, MD PERU
		Michael Matthew Decker, MD, MSc UNITED STATES
		Philippe Noel Neyret, MD, PhD, Prof. FRANCE
		Moderator: Simon W. Young, MD, FRACS NEW ZEALAND
		At the conclusion of this session, participants should have a clear understanding of: How they can introduce a short and optimized hospital stay for their patient with TKA. Should this practice be introduced gradually or as a whole? Should patients be selected or is this practice a state of mind and applicable to most patients? Is this practice beneficial for the patient or are they essentially economic motivations? What are the barriers to outpatient arthroplasty? Report on global LOS differences - 2% TKA, 12% UKA, PF 20%

11:45 - 12:45	Session 5. Surgical Techniques UKA The Theatre
11:45 - 12:45		Surgical Techniques UKA		Translation
		Chair: Guillaume Demey, MD FRANCE
		James Chow, MD UNITED STATES
		Gavin William Clark, MBBS, FRACS AUSTRALIA
		Magaly Iñiguez, MD CHILE
		Peter James McEwen, MBBS FRACS(Orth) FAOrthA DIpModLang A/Prof AUSTRALIA
		Moderator: Andrew James Price, DPhil, FRCS(Orth) UNITED KINGDOM
		At the conclusion of this session, participants should have an improved knowledge of the surgical options available when performing UKA. This is becoming a question of conventional instruments versus robots.

14:15 - 15:15	Session 6. Unicompartmental OA Case-Based Discussion The Theatre
14:15 - 15:15		Unicompartmental OA Case-Based Discussion		Translation
		Chair: Andrew James Price, DPhil, FRCS(Orth) UNITED KINGDOM
		James Chow, MD UNITED STATES
		Gavin William Clark, MBBS, FRACS AUSTRALIA
		Fares S. Haddad, MCh(Orth), BSc, FRCS(Orth) UNITED KINGDOM
		Peter James McEwen, MBBS FRACS(Orth) FAOrthA DIpModLang A/Prof AUSTRALIA
		Moderator: Guillaume Demey, MD FRANCE
		At the conclusion of this session, participants should have a clear understanding of: How to make the correct decision to proceed to unicompartmental replacement. When to choose alternatives including HTO, DFO, and TKA. What are the indications for combined procedure: UKA and ACL. Overcoming the technical challenges of UKA.

15:15 - 15:45	Session 7. Patellofemoral Arthroplasty The Theatre
15:15 - 15:45		Patellofemoral Arthroplasty		Translation
		Chair: Nicolaas C. Budhiparama, MD, PhD (LUMC, NL), PhD (UGM, ID), FICS, Prof. INDONESIA
		Myles R. J. Coolican, FRACS AUSTRALIA
		Sam Oussedik, FRCS UNITED KINGDOM
		Daniel C. Wascher, MD UNITED STATES
		Moderator: Magaly Iñiguez, MD CHILE
		At the conclusion of this session, participants should have a clear understanding of the indications and contraindications for Isolated Patellofemoral Arthroplasty.

16:15 - 16:45	Session 8. Optimizing Patellar Resurfacing in TKA The Theatre
16:15 - 16:45		Optimizing Patellar Resurfacing in TKA		Translation
		Chair: Michael Matthew Decker, MD, MSc UNITED STATES
		Ken Okazaki, MD, PhD, Prof. JAPAN
		David A. Parker, MBBS, BMedSc, FRACS AUSTRALIA
		Hilde Vandenneucker, MD, PhD, Prof BELGIUM
		Moderator: Mark G. Clatworthy, FRACS NEW ZEALAND
		At the conclusion of this session, participants will be aware of the different approaches around the world to patellar resurfacing as well as the types of implants available and data on outcomes. Most of the session will be addressing the various techniques to prepare the patella with a goal of achieving a well-functioning and pain free extensor mechanism with minimal complications.

16:45 - 17:45	Session 9. Robotics and New Technologies The Theatre
16:45 - 17:43		Robotics and New Technologies		Translation
		Chair: Fares S. Haddad, MCh(Orth), BSc, FRCS(Orth) UNITED KINGDOM
		Nicolaas C. Budhiparama, MD, PhD (LUMC, NL), PhD (UGM, ID), FICS, Prof. INDONESIA
		James Chow, MD UNITED STATES
		Sebastien Lustig, MD, PhD, Prof. FRANCE
		Sachin Tapasvi, MBBS, MS, DNB, FRCS INDIA
		Stefaan Van Onsem, MD, PhD BELGIUM
		Moderator: David A. Parker, MBBS, BMedSc, FRACS AUSTRALIA
		At the conclusion of this session, participants should have a clear understanding of: What changes have occurred with robotic arthroplasty in the last 2 years and where will augmented reality, artificial intelligence and smart implants take us into the future. What other new technologies are available and is it useful.

17:45 - 18:00	Summary of Key Messages from the Day The Theatre
17:45 - 18:00		Summary of Key Messages from the Day		Translation
		Director: Myles R. J. Coolican, FRACS AUSTRALIA

08:15 - 08:30	Welcome to Day Two The Theatre
08:15 - 08:30		Introduction Welcome to Day Two		Translation
		Director: Myles R. J. Coolican, FRACS AUSTRALIA
		Director: Philippe Noel Neyret, MD, PhD, Prof. FRANCE

08:30 - 10:30	Session 10. Meet the Experts: Primary TKA The Theatre
08:30 - 10:30		Meet the Expert Primary TKA		Translation Details
		Chair: Peter Verdonk, MD, PhD BELGIUM
		Moderator: Mark G. Clatworthy, FRACS NEW ZEALAND
		Moderator: Myles R. J. Coolican, FRACS AUSTRALIA
		Moderator: Samuel J MacDessi, MBBS FRACS FAOrthA PhD AUSTRALIA
		At the conclusion of this session, participants should have a clear understanding of: How to plan for a routine TKA and one in the presence of severe deformity. How to use different implants, technology and strategies in complex cases. When to independently or concurrently address extra-articular deformity. Strategies to optimize results in the presence of preoperative stiffness. Issues to consider in patients with neurologic conditions such as Parkinson’s disease. How the presence of stiffness and severe deformity impact outcomes.

11:00 - 12:00	Session 11. Meet the Experts: Extensor Mechanism Problems The Theatre
11:00 - 12:00		Meet the Expert Extensor Mechanism Problems		Translation Details
		Chair: Sam Oussedik, FRCS UNITED KINGDOM
		Moderator: Claudia Arias, MD PERU
		Moderator: Magaly Iñiguez, MD CHILE
		Moderator: Philippe Noel Neyret, MD, PhD, Prof. FRANCE
		At the conclusion of this session, participants will have been exposed to the common extensor mechanism problems seen after TKA and be aware of how to prevent as well as manage.

13:30 - 14:15	Session 12: Meet the Experts: Revision Cases: Infection The Theatre
13:30 - 14:15		Meet the Expert Revision Cases: Infection		Translation Details
		Chair: Simon W. Young, MD, FRACS NEW ZEALAND
		Moderator: Michael Matthew Decker, MD, MSc UNITED STATES
		Moderator: Michel Vancabeke, MD BELGIUM
		At the conclusion of this session, participants should have a clear understanding of: Optimal techniques for infection prevention in arthroplasty. Optimal techniques for investigating possible infection. Decision making to determine single versus same day 2 stage and 2 stage revision for infection. Best surgical techniques in single and double stage revision to optimize success. Outcomes of revision for infection. Assessment of unexplained pain in a knee arthroplasty with emphasis on diagnosis and the exclusion of metal allergy and how to manage.

14:15 - 15:00	Session 13. Meet the Experts: Aseptic Revision Cases The Theatre
14:15 - 15:00		Aseptic Revision Cases		Translation
		Chair: David H. Figueroa, MD CHILE
		Moderator: Francesco Benazzo, MD, Prof. ITALY
		Moderator: Peter James McEwen, MBBS FRACS(Orth) FAOrthA DIpModLang A/Prof AUSTRALIA
		Moderator: Daniel C. Wascher, MD UNITED STATES
		At the conclusion of this session, participants will have a clear understanding of how to manage common challenges of aseptic revision surgery. This includes preoperative assessment, surgical exposure, implant removal, assessment and management of bone stock loss, reestablishment of joint height, stems, cones and offset couplers and implant selection to achieve stability in two areas.

15:30 - 16:15	Session 14. Meet the Experts: Revision Cases: Instability The Theatre
15:30 - 16:15		Meet the Expert Revision Cases: Instability		Translation Details
		Chair: Mark G. Clatworthy, FRACS NEW ZEALAND
		Moderator: Sachin Tapasvi, MBBS, MS, DNB, FRCS INDIA
		At the conclusion of this session, participants should have a clear understanding of: The different scenarios that lead to TKA instability and their clinical manifestations. The different forms of presentation of corona and sagittal instability as well as multiple instabilities and instability of the patellofemoral joint. The treatment of the different patterns of TKA instability.

16:15 - 17:15	Session 15. Disasters and How They Can Be Managed The Theatre
16:15 - 17:15		Disasters and How They Can Be Managed		Translation
		Chair: David A. Parker, MBBS, BMedSc, FRACS AUSTRALIA
		Moderator: Philippe Noel Neyret, MD, PhD, Prof. FRANCE
		At the conclusion of this session, participants will understand that all surgeons will still have intraoperative and early postoperative complications. These will be presented with each faculty member presenting his or her own complication and how it was managed and the outcome.

17:15 - 17:30	Summary of Key Messages from the Day The Theatre
17:15 - 17:30		Summary of Key Messages from the Day		Translation
		Director: Myles R. J. Coolican, FRACS AUSTRALIA